Publication:
Inflammatory complications of vocal fold injection with hyaluronic acid: A multiinstitutional study

dc.contributor.authorEnver, Necati
dc.contributor.authorAzizli, Elad
dc.contributor.authorAkbulut, Sevtap
dc.contributor.authorTatar, Emel Cadalli
dc.contributor.authorYelken, Muhammed Kursad
dc.contributor.authorOzturk, Kayhan
dc.contributor.authorBirkent, Ahmet Hakan
dc.contributor.authorBuyukatalay, Zahide Ciler
dc.contributor.authorOzgursoy, Ozan Bagis
dc.contributor.authorOguz, Haldun
dc.contributor.buuauthorCoskun, Hakan
dc.contributor.buuauthorCOŞKUN, HAMDİ HAKAN
dc.contributor.departmentBursa Uludağ Üniversitesi/Tıp Fakültesi.
dc.contributor.orcid0000-0002-0881-1444
dc.date.accessioned2024-06-14T13:18:14Z
dc.date.available2024-06-14T13:18:14Z
dc.date.issued2021-01-01
dc.descriptionBu çalışma, 24-28 Haziran 2017 tarihleri arasında Paris[Fransa]’da düzenlenen 17. ENT World Congress of Otorhinolaryngology of the International-Federation-of-Otolaryngological-Societies (IFOS)’da bildiri olarak sunulmuştur.
dc.description.abstractBackground/aim: This study aimed to assess the inflammatory adverse reactions of vocal fold injection laryngoplasty with hyaluronic acid.Materials and methods: This study was a retrospective chart review of patients who underwent vocal fold injection augmentation with HA injection from January 2005 to September 2016 in nine different institutions. Demographic data, indication for injection, injection techniques, types of injection material, settings of procedure, and complications were reviewed. The types of complication, onset time, and management of complications were also noted.Results: In all, 467 patients were identified. The majority of patients had been injected under general anesthesia (n = 382, 84.7%). For injection material, two different types of hyaluronic acid were used: hyaluronic acid alone or hyaluronic acid with dextranomer. Complications occurred in nine patients (1.9%). The majority of complications were inflammatory reactions (n = 7, 1.47%). Main symptoms were dysphonia and/or dyspnea with an onset of 0 h to 3 weeks after the hyaluronic acid injection. Three patients were hospitalized, one of which was also intubated and observed in the intensive care unit for 24 h. Systemic steroids and antibiotics were the main medical treatment in the majority of cases. There was no statistical difference in complication rates between patients who received hyaluronic acid and those who received hyaluronic acid with dextranomer (P = 0.220).Conclusion: Hyaluronic acid can be considered as a safe substance for the injection of vocal folds with a low risk of inflammatory reaction.
dc.description.sponsorshipInt Federat Otolaryngol Soc
dc.identifier.doi10.3906/sag-2008-5
dc.identifier.endpage825
dc.identifier.issn1300-0144
dc.identifier.issue2
dc.identifier.startpage819
dc.identifier.urihttps://doi.org/10.3906/sag-2008-5
dc.identifier.urihttps://hdl.handle.net/11452/42224
dc.identifier.volume51
dc.identifier.wos000646231300003
dc.indexed.wosWOS.SCI
dc.indexed.wosWOS.ISTP
dc.language.isoen
dc.publisherTUBİTAK
dc.relation.journalTurkish Journal Of Medical Sciences
dc.relation.publicationcategoryKonferans Öğesi – Uluslararası
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectInjectable fillers
dc.subjectLaryngoplasty
dc.subjectVocal fold injection
dc.subjectHyaluronic acid
dc.subjectHyaluronic acid with dextranomer
dc.subjectInflammatory reaction
dc.subjectVocal fold paralysis
dc.subjectSulcus vocalis
dc.subjectScience & technology
dc.subjectLife sciences & biomedicine
dc.subjectMedicine, general & internal
dc.subjectGeneral & internal medicine
dc.titleInflammatory complications of vocal fold injection with hyaluronic acid: A multiinstitutional study
dc.typeArticle
dc.typeProceedings Paper
dspace.entity.typePublication
relation.isAuthorOfPublication2d0e3678-5cd4-407e-9256-0d00a7ce74d3
relation.isAuthorOfPublication.latestForDiscovery2d0e3678-5cd4-407e-9256-0d00a7ce74d3

Files

Collections